Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- befree-20150227 importedOn "2015-02-27" NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_assertion wasGeneratedBy ECO_0000203 NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_assertion wasDerivedFrom befree-20150227 NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_assertion SIO_000772 21898529 NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_assertion evidence source_evidence_literature NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.
- NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_assertion description "[Therefore, we propose that CTA-specific immunotherapy for AML should preferentially target PRAME and/or should be combined with the application of demethylating agents opening the perspective for alternative targets like CTA SSX-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874527.RA94dNxC3nPOtYEzffghFJeDXIcmXPNE9IZQqvmAB2Jao130_provenance.